IMMUNOVANT INC (IMVT)

US45258J1025 - Common Stock

30.7  -0.78 (-2.48%)

After market: 30.7 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

 MRQ
(2023-12-31)		 2023
(2023-3-31)		 2022
(2022-3-31)		 2021
(2021-3-31)		 2020
(2020-3-31)
ASSETS
Current Assets
Cash
690.94M376.50M493.80M400.10M100.60M
Receivables
1.03M900.00K12.90M500.00K3.00M
Other Current Assets
18.81M26.90M6.30M8.30M5.50M
Total Current Assets
710.78M404.30M512.90M409.00M109.10M
 
Non-Current Assets
PPE Net
670.00K1.50M2.60M3.50M100.00K
Other Non-Current Assets
N/AN/AN/A0.00200.00K
Total Non-Current Assets
670.00K1.50M2.70M3.50M300.00K
 
TOTAL ASSETS
711.45M405.80M515.60M412.50M109.40M
 
LIABILITIES
Current Liabilities
Short Term Debt
0.000.000.000.000.00
Accrued Expenses
28.19M41.60M25.70M16.30M10.90M
Accounts Payable
3.91M1.40M18.60M2.40M1.20M
Other Current Liabilities
N/A400.00K200.00K0.003.20M
Total Current Liabilities
32.10M43.30M44.50M18.80M15.30M
 
Non-Current Liabilities
Long Term Debt
0.000.000.000.000.00
Other Non-Current Liabilities
0.000.001.20M2.20MN/A
Total Non-Current Liabilities
0.000.001.20M2.20M0.00
 
TOTAL LIABILITIES
32.10M43.30M45.70M21.00M15.30M
 
SHAREHOLDERS' EQUITY
Retained Earnings
-750.36M-566.30M-355.40M-198.70M-91.20M
Additional Paid In Capital
1.43B928.00M824.80M590.40M185.30M
Common Shares
14.00K0.000.000.000.00
Other Shareholders' Equity
-600.00K900.00K400.00K-300.00K0.00
Shares Outstanding
145.09M130.30M116.50M98.00M56.50M
Tangible Book Value per Share
4.682.784.033.991.67
Total Shareholders' Equity
679.34M362.50M469.80M391.50M94.10M
 
TOTAL LIABILITIES AND EQUITY
711.45M405.80M515.60M412.50M109.40M
 
Statistics
Current Ratio
22.149.3411.5321.767.13
Return On Assets (ROA)
-34.22%-51.99%-30.40%-26.04%-60.69%
Return On Equity (ROE)
-35.84%-58.20%-33.36%-27.44%-70.55%

All data in USD

Charts